AVTX
#2622
Avalo Therapeutics, Inc. - Common Stock
13.2 4 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.00%
Monthly Change
-19.42%
6 month change
-2.36%
Year Change
-2.58%
Previous Close
13.6 5
Open
13.5 6
Low
13.1 3
High
13.6 9
Financials
2023
Current report, 20 Dec 2023
Avalo Therapeutics, Inc. current report, 20 December 2023
8-K
Current report, 07 Dec 2023
Avalo Therapeutics, Inc. current report, 07 December 2023
8-K
Current report, 14 Nov 2023
Avalo Therapeutics, Inc. current report, 14 November 2023
8-K
Current report, 09 Nov 2023
Avalo Therapeutics, Inc. current report, 09 November 2023
8-K
Current report, 27 Oct 2023
Avalo Therapeutics, Inc. current report, 27 October 2023
8-K
Current report, 16 Oct 2023
Avalo Therapeutics, Inc. current report, 16 October 2023
8-K
Current report, 03 Oct 2023
Avalo Therapeutics, Inc. current report, 03 October 2023
8-K
Quarterly report, Q3 FY2023
Avalo Therapeutics, Inc. quarterly report, Q3 FY2023
10-Q
Current report, 22 Sep 2023
Avalo Therapeutics, Inc. current report, 22 September 2023
8-K
Current report, 13 Sep 2023
Avalo Therapeutics, Inc. current report, 13 September 2023
8-K